scispace - formally typeset
Open AccessJournal ArticleDOI

Combating COVID-19: The role of drug repurposing and medicinal plants

TLDR
The aim of this mini-review is to give an overview of identified repurposed anti-COVID-19 drugs which are currently under clinical trials and explore antiviral medicinal plants as adjunct or supportive therapy.
About
This article is published in Journal of Infection and Public Health.The article was published on 2021-04-01 and is currently open access. It has received 40 citations till now. The article focuses on the topics: Literature survey & Drug repositioning.

read more

Citations
More filters
Journal ArticleDOI

Targeting SARS-CoV-2 nsp13 Helicase and Assessment of Druggability Pockets: Identification of Two Potent Inhibitors by a Multi-Site In Silico Drug Repurposing Approach

TL;DR: In this article , a detailed conservation analysis of the SARS-CoV-2 helicase genome was performed to predict the druggable enzyme's binding pockets and a structure-based virtual screening was used to identify valuable compounds that are capable of recognizing multiple nsp13 pockets.
Journal ArticleDOI

Cultural belief and medicinal plants in treating COVID 19 patients of Western Colombia

TL;DR: In this paper , the authors focused on the importance of traditional, cultural and generations history with reference to the use of importance and significance of medicinal plants, especially to find out a strategy to fight the new virus.
Journal ArticleDOI

COVID-19 therapeutics: Clinical application of repurposed drugs and futuristic strategies for target-based drug discovery

TL;DR: In this article , the up-to-date information on target-based pharmacological classification of repurposed drugs, the potential mechanism of actions, and the current clinical trial status of various drugs which are under repurposing since early 2020 are discussed.
Journal ArticleDOI

Some flavolignans as potent SARS-CoV-2 inhibitors via molecular docking, molecular dynamic simulations and ADME Analysis.

TL;DR: According to the results obtained from molecular docking studies, molecular dynamic simulations, and ADME analysis, it can be proposed that the flavolignans which can be used to design effective antiviral drug candidates against the SARS-CoV-2, can be tried for promising and effective inhibitors of the SAR's main protease in vitro and in vivo studies.
References
More filters
Journal ArticleDOI

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.

TL;DR: This study evaluated the antiviral efficiency of five FAD-approved drugs including ribavirin, penciclovir, nitazoxanide, nafamostat, chloroquine and two well-known broad-spectrum antiviral drugs remdesivir and favipiravir against a clinical isolate of 2019-nCoV in vitro.
Journal ArticleDOI

First Case of 2019 Novel Coronavirus in the United States.

TL;DR: This case highlights the importance of close coordination between clinicians and public health authorities at the local, state, and federal levels, as well as the need for rapid dissemination of clinical information related to the care of patients with this emerging infection.
Related Papers (5)